DJIA 17,150.43 176.12 1.04%
NASDAQ 4,564.74 15.52 0.34%
S&P 500 1,992.90 10.60 0.53%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

17.35 0.50 (2.97%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLDX $17.35 2.97%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.73
Previous Close $16.85
Daily Range $16.35 - $17.35
52-Week Range $10.76 - $33.33
Market Cap $1.6B
P/E Ratio -14.04
Dividend (Yield) $0.00 (0.0%)
Volume 888,276
Average Daily Volume 1,978,202
Current FY EPS -$1.32





Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website:

News & Commentary

3 Beaten Down Biotech Stocks to Buy Now

The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.

Celldex Therapeutics (CLDX) Highlighted As Today's Perilous Reversal Stock

Celldex Therapeutics Breaks Resistance

Strong On High Volume: Celldex Therapeutics (CLDX)

Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

Top Analyst Upgrades and Downgrades: Altria, Celldex, Linkedin, Nike, Seadrill, Verizon and More

Why You Shouldn't Bet Against Celldex Therapeutics (CLDX) Stock - Tale of the Tape

Celldex Therapeutics' CEO Presents at Morgan Stanley Healthcare Conference (Transcript)

Steve Brozak: Big-Picture Biotech Stocks Rule The Future

See More CLDX News...

CLDX's Top Competitors

CLDX $17.35 (2.97%)
Current stock: CLDX
AMGN $160.99 (1.33%)
Current stock: AMGN
GILD $114.07 (3.03%)
Current stock: GILD
BIIB $322.72 (2.43%)
Current stock: BIIB